Purpose: To report a patient with generalized retinal toxicity to mitogen-activated protein inhibitors.
Methods: Retrospective case report.
Results: Full-field electroretinogram findings indicate a generalized toxicity to the use of the mitogen-activated protein inhibitor trametinib.